WHO ICTRP trial
Short courses of chemotherapy followed by 90Y-Ibritumomab tiuxetan for relapsed…
JPRN-UMIN000012957 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000012957 |
|---|---|
| Public title | Short courses of chemotherapy followed by 90Y-Ibritumomab tiuxetan for relapsed low grade B cell lymphoma |
| Scientific title | Short courses of chemotherapy followed by 90Y-Ibritumomab tiuxetan for relapsed low grade B cell lymphoma - CLOBRZ study |
| Primary sponsor | Tokyo Medical and Dental University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Relapsed low grade B cell lymphoma |
| Interventions | 2~3 courses of chemotherapy followed by Y90-Ibritumomab tiuxetan |
| Registration date | Jan 25, 2014 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: